RECARBRIO 500 mg/100mL
imipenem anhydrous, cilastatin, and relebactam anhydrous · INJECTION, POWDER, FOR SOLUTION · Merck Sharp & Dohme LLC
RECARBRIO is a injection, powder, for solution containing imipenem anhydrous, cilastatin, and relebactam anhydrous at 500 mg/100mL, taken intravenous. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- RECARBRIO
- Generic Name
- imipenem anhydrous, cilastatin, and relebactam anhydrous
- NDC Code (Product)
0006-3856- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 500 mg/100mL
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA212819
- Drug Class
- Renal Dehydropeptidase Inhibitor [EPC]; Penem Antibacterial [EPC]
- Marketing Start
- 01/06/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is RECARBRIO used for?
RECARBRIO contains imipenem anhydrous, cilastatin, and relebactam anhydrous. It is a injection, powder, for solution taken intravenous. Consult your doctor for specific uses.
Is RECARBRIO a controlled substance?
RECARBRIO is not classified as a controlled substance by the DEA.
What is the generic name for RECARBRIO?
The generic name for RECARBRIO is imipenem anhydrous, cilastatin, and relebactam anhydrous. There are no other listed brand versions of imipenem anhydrous, cilastatin, and relebactam anhydrous.
What is the NDC code for RECARBRIO 500 mg/100mL?
The NDC (National Drug Code) for RECARBRIO 500 mg/100mL is 0006-3856, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)